Panacea Biotec Limited — Others, 14-02-2025: Change in Director(s)

Panacea Biotec Ltd has announced a board meeting where it approved the standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, noting total income from operations of ₹24.20 crore and a net profit after tax of ₹4.92 crore. Additionally, the company confirmed several appointments and reappointments of directors, including Mr. Sandeep Jain as Joint Managing Director and Mr. Harshet Jain as a Whole-time Director. The changes in management aim to strengthen governance and operational oversight. This update may provide a positive outlook for investors, reflecting strategic continuity and potential growth.